Manipal Health Enterprises Ltd (MANIPALHOS) Q1 FY27 Results Analysis: Revenue Surges 38%, PAT Slips 7.5%

Manipal Health Enterprises Ltd's Q1 FY27 numbers came in mixed, with revenue of Rs. 3,090.63 Cr (+38.12% YoY) and PAT growth of -4.18% YoY. Here's a quick read of what worked, what to watch, and what management said.

Quarter Snapshot

Revenue grew 38% YoY driven by M&A, but PAT fell 7.5% due to 206bps margin compression and 123% finance cost surge. IPO proceeds post-quarter are expected to reduce debt and interest costs from Q2, offering a potential earnings catalyst.

Key Investment Insights

Key Positives

• Consolidated revenue grew 38.12% YoY to Rs.3,090.63 Cr, driven by full-quarter contribution from Sahyadri acquisition.
• Standalone revenue grew 28.15% YoY to Rs.1,048.30 Cr, indicating organic expansion of the parent entity network.
• IPO raised Rs.8,000 Cr from fresh issue, proceeds earmarked for subsidiary debt repayment, expected to reduce finance costs from Q2FY27.
• Subsidiaries contributed Rs.2,042 Cr of revenue and Rs.116.12 Cr of PAT attributable to owners.

Risk Factors

• EBITDA margin contracted 206 bps YoY to 23.33%, driven by a 251 bps rise in other expenses as a share of revenue.
• PAT attributable to owners declined 7.48% YoY despite 38% revenue growth, with finance costs surging 122.83% YoY.
• Finance costs of Rs.293.27 Cr surged 122.83% YoY due to acquisition debt and NCDs, with full debt load carried through the quarter.
• Standalone EBITDA margin compressed 471 bps YoY to 22.57%, indicating organic cost pressures from staff increments and higher other expenses.
• 100% of promoter holding is encumbered against total debt of Rs.15,905 Cr, implying high financial leverage.